1. Home
  2. RAVE vs ELUT Comparison

RAVE vs ELUT Comparison

Compare RAVE & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rave Restaurant Group Inc.

RAVE

Rave Restaurant Group Inc.

N/A

Current Price

$3.16

Market Cap

48.5M

ML Signal

N/A

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.90

Market Cap

41.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAVE
ELUT
Founded
1958
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.5M
41.9M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
RAVE
ELUT
Price
$3.16
$0.90
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
41.3K
56.9K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
11.76
146.77
EPS
0.15
N/A
Revenue
$15,120,000.00
$12,293,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.83
P/E Ratio
$20.87
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$0.50
52 Week High
$3.75
$2.50

Technical Indicators

Market Signals
Indicator
RAVE
ELUT
Relative Strength Index (RSI) 47.43 44.57
Support Level $3.07 $0.88
Resistance Level $3.48 $1.18
Average True Range (ATR) 0.15 0.06
MACD -0.03 0.00
Stochastic Oscillator 25.30 36.43

Price Performance

Historical Comparison
RAVE
ELUT

About RAVE Rave Restaurant Group Inc.

Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn Franchising and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The corporate administration and other segments. The Pizza Inn Franchising segment accounts for the majority of the company's revenue. Geographically, it generates the majority of the revenue from the United States.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: